Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

But the 72-year-old Mendoza, who has not been diagnosed with Alzheimer’s, isn’t getting the exam at a doctor’s office or a clinical lab. She’s in a comfortable and familiar place, sipping Cuban coffee ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Compared to people with other jobs, these taxi drivers had changes in their hippocampus. It is this part of the brain that is ...

The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

The Alzheimer’s Foundation of America is offering scholarships of up to $5,000 to college-bound high school seniors affected ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The Community Foundation for Brevard recently awarded $100,000 to Florida Institute of Technology’s Shaohua Xu, Ph.D., to ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

Related: How Following the Mediterranean Diet Could Reduce Brain Age by 50%, According to a New Study For this study, ...

Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...